Magnesium for the prevention and treatment of cardiovascular disease

Open Heart

Volumn 5, Issue 2, 2018, Pages

  Dinicolantonio, James J ^a   Liu, Jing ^b   O'Keefe, James H ^a  

^a Saint Luke's Mid America Heart Institute   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cardiovascular disease; hypertension; magnesium

Indexed keywords

MAGNESIUM;

ATHEROSCLEROSIS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY SPASM; DIETARY INTAKE; DRUG INTERACTION; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEART MUSCLE INJURY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; INCIDENCE; MAGNESIUM DEFICIENCY; MITRAL VALVE PROLAPSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA; THROMBOSIS;

EID: 85049757659     PISSN: None     EISSN: 20533624     Source Type: Journal    
DOI: 10.1136/openhrt-2018-000775     Document Type: Review

References (118)

1. National Institutes of Health. Magnesium. https://ods. od. nih. gov/FactSheets/magnesium/.
2. Volpe SL. Magnesium. In: Erdman JW, Macdonald IA, Zeisel SH, eds. Present knowledge in nutrition. 10th ed. Ames, Iowa: John Wiley & Sons, 2012:459-74.
3. Mazur A, Maier JA, Rock E, et al. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007;458:48-56.
4. Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA 1990;263:3063-4.
5. Ryzen E, Elkayam U, Rude RK. Low blood mononuclear cell magnesium in intensive cardiac care unit patients. Am Heart J 1986;111:475-80.
6. Elin RJ. Assessment of magnesium status. Magnes Res 2010;23:194-8.
7. Ryzen E, Elbaum N, Singer FR, et al. Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency. Magnesium 1985;4:137-47.
8. DiNicolantonio JJ, O'Keefe JH, Wilson W. Correction: Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart 2018;5.
9. Reinhart RA. Magnesium metabolism. A review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med 1988;148:2415-20.
10. Ryan MF, Ryan MP. Lymphocyte electrolyte alterations during magnesium deficiency in the rat. Irish J Med Sci 1979;148:pp108-9.
11. Elin RJ. Status of the determination of magnesium in mononuclear blood cells in humans. Magnesium 1988;7:1988300-5.
12. Lim P, Jacob E. Magnesium deficiency in patients on long-term diuretic therapy for heart failure. Br Med J 1972;3:620-2.
13. Purvis JR, Movahed A. Magnesium disorders and cardiovascular diseases. Clin Cardiol 1992;15:556-68.
14. Fischer PW, Giroux A. Effects of dietary magnesium on sodium-potassium pump action in the heart of rats. J Nutr 1987;117:2091-5.
15. Madden JA, Willems WJ, Smith GA, et al. Sodium kinetics and membrane potential in aorta of magnesium-deficient rats. Magnesium 1984;3:73-80.
16. Sheehan JP, Seelig MS. Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease. Magnesium 1984;3:301-14.
17. Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol 1992;263:R734-R737.
18. Marier JR. Magnesium content of the food supply in the modernday world. Magnesium 1986;5:1-8.
19. Lichton IJ. Dietary intake levels and requirements of Mg and Ca for different segments of the U.S. population. Magnesium 1989;8:117-23.
20. Catling LA, Abubakar I, Lake IR, et al. A systematic review of analytical observational studies investigating the association between cardiovascular disease and drinking water hardness. J Water Health 2008;6:433-42.
21. Sharper AG, Water S. Heart attacks, and stroke. JAMA 1974;7:130-1.
22. Anderson TW, Neri LC, Schreiber GB, et al. Letter: Ischemic heart disease, water hardness and myocardial magnesium. Can Med Assoc J 1975;113:199-203.
23. Abu-Zeid HA. The water factor and mortality from ischemic heart disease: a review and possible explanations for inconsistent findings with additional data from Manitoba. Arch Environ Health 1979;34:328-36.
24. Neri LC, Hewitt D, Mandel JS. Risk of sudden death in soft water areas. Am J Epidemiol 1971;94:101-4.
25. Lindeman RD, Assenzo JR. Correlations between water hardness and cardiovascular deaths in oklahoma counties. Am J Public Health Nations Health 1964;54:1071-7.
26. Allwright SP, Coulson A, Detels R, et al. Mortality and waterhardness in three matched communities in Los Angeles. Lancet 1974;2:860-4.
27. Mulcahy R. The influence of water hardness and rainfall on the incidence of cardiovascular and cerebrovascular mortality in Ireland. J Ir Med Assoc 1964;55:196417-8.
28. Singh RB, Rastogi SS, Mehta PJ, et al. Magnesium metabolism in essential hypertension. Acta Cardiol 1989;44:313-22.
29. Altura BM, Altura BT. Interactions of Mg and K on blood vessels- aspects in view of hypertension. Review of present status and new findings. Magnesium;3:1984175-94.
30. Ryan MP, Brady HR. The role of magnesium in the prevention and control of hypertension. Ann Clin Res 1984;16:81-8.
31. Shibutani Y, Sakamoto K, Katsuno S, et al. Serum and erythrocyte magnesium levels in junior high school students: relation to blood pressure and a family history of hypertension. Magnesium 1988;7:188-94.
32. Rylander R, Arnaud MJ. Mineral water intake reduces blood pressure among subjects with low urinary magnesium and calcium levels. BMC Public Health 2004;4:56.
33. Zhang X, Li Y, Del Gobbo LC, et al. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension 2016;68:324-33.
34. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012;66:411-8.
35. Hattori K, Saito K, Sano H, et al. Intracellular magnesium deficiency and effect of oral magnesium on blood pressure and red cell sodium transport in diuretic-treated hypertensive patients. Jpn Circ J 1988;52:1249-56.
36. Rosanoff A, Plesset MR. Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis. Magnes Res 2013;26:93-9.
37. Ahmad A, Bloom S. Sodium pump and calcium channel modulation of Mg-deficiency cardiomyopathy. Am J Cardiovasc Pathol 1989;2:277-83.
38. Freedman AM, Atrakchi AH, Cassidy MM, et al. Magnesium deficiency-induced cardiomyopathy: protection by vitamin E. Biochem Biophys Res Commun 1990;170:1102-6.
39. Herbaczynska-Cedro K, Gajkowska B. Effect of magnesium on myocardial damage induced by epinephrine. Ultrastructural and cytochemical study. Cardioscience 1992;3:197-203.
40. Giles TD, Iteld BJ, Rives KL. The cardiomyopathy of hypoparathyroidism. Chest 1981;79:225-9.
41. Seelig MS. Magnesium deficiency in the pathogenesis of disease: early roots of cardiovasculac skeletal, and renal abnormalities, 1980.
42. Valiathan MS, Kartha CC, Panday VK, et al. A geochemical basis for endomyocardial fibrosis. Cardiovasc Res 1986;20:679-82.
43. Valiathan SM, Kartha CC. Endomyocardial fibrosis-the possible connexion with myocardial levels of magnesium and cerium. Int J Cardiol 1990;28:1-5.
44. Altura BM, Altura BT. Biochemistry and pathophysiology of congestive heart failure: is there a role for magnesium? Magnesium 1986;5:134-43.
45. Dyckner T, Wester PO. Magnesium deficiency in congestive heart failure. Acta Pharmacol Toxicol 1984;54:119-23.
46. Dyckner T, Wester PO. Renal excretion of electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure. Acta Med Scand 1985;218:443-8.
47. Ryan MP, Ryan MF, Counihan TB. The effect of diuretics on lymphocyte magnesium and potassium. Acta Med Scand 1981;209:153-61.
48. Abraham AS. Diuretics and intracellular cations. Drugs 1986;31(Suppl 4):109-11.
49. Dyckner T, Wester PO. Intracellular magnesium loss after diuretic administration. Drugs 1984;28 Suppl 1:161-6.
50. Gottlieb SS. Importance of magnesium in congestive heart failure. Am J Cardiol 1989;63:G39-G42.
51. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 1985;72:681-5.
52. Flink EB, Brick JE, Shane SR. Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction. Arch Intern Med 1981;141:441-3.
53. Wester PO, Dyckner T. Intracellular electrolytes in cardiac failure. Acta Med Scand Suppl 1986;707:33-6.
54. Song EK, Kang SM. Micronutrient deficiency independently predicts adverse health outcomes in patients with heart failure. J Cardiovasc Nurs 2017;32:47-53.
55. Storm W, Zimmerman JJ. Magnesium deficiency and cardiogenic shock after cardiopulmonary bypass. Ann Thorac Surg 1997;64:572-7.
56. Gottlieb SS, Baruch L, Kukin ML, et al. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol 1990;16:827-31.
57. Bashir Y, Sneddon JF, Staunton HA, et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 1993;72:1156-62.
58. Ralston MA, Murnane MR, Kelley RE, et al. Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation 1989;80:573-80.
59. Cohen L, Laor A, Kitzes R. Prolonged Q-Tc interval and decreased lymphocyte magnesium in congestive heart failure. Magnesium 1984;3:164-8.
60. Davis WH, Ziady F. The effect of oral magnesium chloride therapy on the QTc and QUc intervals of the electrocardiogram. S Afr Med J 1978;53:591-3.
61. Laban E, Charbon GA. Magnesium and cardiac arrhythmias: nutrient or drug? J Am Coll Nutr 1986;5:521-32.
62. Boyd JC, Bruns DE, DiMarco JP, et al. Relationship of potassium and magnesium concentrations in serum to cardiac arrhythmias. Clin Chem 1984;30:754-7.
63. Dyckner T, Wester PO. Potassium/magnesium depletion in patients with cardiovascular disease. Am J Med 1987;82:11-17.
64. Hollifield JW. Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy. Am J Med 1986;80:8-12.
65. Hollifield JW. Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension. Am J Med 1984;77:28-32.
66. Dyckner T, Wester PO. Relation between potassium, magnesium and cardiac arrhythmias. Acta Med Scand Suppl 1981;647:163-9.
67. Dyckner T, Wester PO. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment. Am Heart J 1979;97:12-18.
68. Cannon LA, Lloyd T. Magnesium levels in cardiac arrest victims: relation to successful resuscitation. Ann Emerg Med 1986;15:616. 190/639.
69. Ganga HV, Noyes A, White CM, et al. Magnesium adjunctive therapy in atrial arrhythmias. Pacing Clin Electrophysiol 2013;36:1308-18.
70. Maurat JP, Kantelip JP, Anguenot T, et al. [Cardiovascular pathology and magnesium]. Therapie 1993;48:599-607.
71. Khan AM, Lubitz SA, Sullivan LM, et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation 2013;127:33-8.
72. DeCarli C, Sprouse G, LaRosa JC. Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. Am J Cardiol 1986;57:956-9.
73. Lewis RV, Tregaskis B, McLay J, et al. Oral magnesium reduces ventricular ectopy in digitalised patients with chronic atrial fibrillation. Eur J Clin Pharmacol 1990;38:107-10.
74. Eray O, Akca S, Pekdemir M, et al. Magnesium efficacy in magnesium deficient and nondeficient patients with rapid ventricular response atrial fibrillation. Eur J Emerg Med 2000;7:287-90.
75. Cohen L, Kitzes R, Shnaider H. Multifocal atrial tachycardia responsive to parenteral magnesium. Magnes Res 1988;1:239-42.
76. Cohen L, Kitzes R. Magnesium sulfate and digitalis-toxic arrhythmias. JAMA 1983;249:2808-10.
77. Iseri LT. Role of magnesium in cardiac tachyarrhythmias. Am J Cardiol 1990;65:K47-K50.
78. Bean BL, Varghese PJ. Role of dietary magnesium deficiency in the pressor and arrhythmogenic response to epinephrine in the intact dog. Am Heart J 1994;127:96-102.
79. Krasner BS, Girdwood R, Smith H. The effect of slow releasing oral magnesium chloride on the QTc interval of the electrocardiogram during open heart surgery. Can Anaesth Soc J 1981;28:329-33.
80. Raghu C, Peddeswara Rao P, Seshagiri Rao D. Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy. Int J Cardiol 1999;71:209-15.
81. Papaceit J, Moral V, Recio J, et al. [Severe heart arrhythmia secondary to magnesium depletion. Torsade de pointes]. Rev Esp Anestesiol Reanim 1990;37:28-31.
82. Eisenberg MJ. Magnesium deficiency and sudden death. Am Heart J 1992;124:544-9.
83. Singh RB, Singh VP, Cameron EA. Magnesium in atherosclerotic cardiovascular disease and sudden death. Acta Cardiol 1981;36:411-29.
84. Altura BM, Altura BT, Carella A, et al. Hypomagnesemia and vasoconstriction: possible relationship to etiology of sudden death ischemic heart disease and hypertensive vascular diseases. Artery 1981;9:212-31.
85. Turlapaty PD, Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 1980;208:198-200.
86. Altura BM. Sudden-death ischemic heart disease and dietary magnesium intake: is the target site coronary vascular smooth muscle? Med Hypotheses 1979;5:843-8.
87. Ferre S, Baldoli E, Leidi M, et al. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB. Biochim Biophys Acta 2010;1802:952-8.
88. Shah NC, Liu JP, Iqbal J, et al. Mg deficiency results in modulation of serum lipids, glutathione, and NO synthase isozyme activation in cardiovascular tissues: relevance to de novo synthesis of ceramide, serum Mg and atherogenesis. Int J Clin Exp Med 2011;4:103-18.
89. Maier JA, Malpuech-Brugere C, Zimowska W, et al. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 2004;1689:13-21.
90. el-Hindi HM, Amer HA. Effect of thiamine, magnesium, and sulfate salts on growth, thiamine levels, and serum lipid constituents in rats. J Nutr Sci Vitaminol 1989;35:505-10.
91. Altura BT, Brust M, Bloom S, et al. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci U S A 1990;87:1840-4.
92. Stendig-Lindberg G. Sudden death of athletes: is it due to longterm changes in serum magnesium, lipids and blood sugar? J Basic Clin Physiol Pharmacol 1992;3:153-64.
93. Chadda KD, Schultz NA. Magnesium deficiency and coronary vasospasm: role in sudden cardiac death. Magnesium 1982;1:86-94.
94. Yanagisawa-Miwa A, Ito H, Sugimoto T. Effects of insulin on vasoconstriction induced by thromboxane A2 in porcine coronary artery. Circulation 1990;81:1654-9.
95. Tanabe K, Noda K, Kamegai M, et al. Variant angina due to deficiency of intracellular magnesium. Clin Cardiol 1990;13:663-5.
96. Guo H, Cheng J, Lee JD, et al. Relationship between the degree of intracellular magnesium deficiency and the frequency of chest pain in women with variant angina. Herz 2004;29:299-303.
97. Teragawa H, Kato M, Yamagata T, et al. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 2000;118:1690-5.
98. Wiles ME, Wagner TL, Weglicki WB. Effect of acute magnesium deficiency (MgD) on aortic endothelial cell (EC) oxidant production. Life Sci 1997;60:221-36.
99. Kumar BP, Shivakumar K. Depressed antioxidant defense in rat heart in experimental magnesium deficiency. Implications for the pathogenesis of myocardial lesions. Biol Trace Elem Res 1997;60:139-44.
100. Hans CP, Chaudhary DP, Bansal DD. Magnesium deficiency increases oxidative stress in rats. Indian J Exp Biol 2002;40:1275-9.
101. Freedman AM, Cassidy MM, Weglicki WB. Magnesium-deficient myocardium demonstrates an increased susceptibility to an in vivo oxidative stress. Magnes Res 1991;4:185-9.
102. Kharb S, Singh V. Magnesium deficiency potentiates free radical production associated with myocardial infarction. J Assoc Physicians India 2000;48:484-5.
103. Urdal P, Landmark K, Basmo GM. Mononuclear cell magnesium and retention of magnesium after intravenous loading in patients with acute myocardial infarction. Scand J Clin Lab Invest 1992;52:763-6.
104. Rasmussen HS, McNair P, Goransson L, et al. Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test. Arch Intern Med 1988;148:329-32.
105. Parsons RS, Butler T, Sellars EP. The treatment of coronary artery disease with parenteral magnesium sulphate. Med Proc 1959:487.
106. Jeppesen BB. Magnesium status in patients with acute myocardial infarction: a pilot study. Magnesium 1986;5:95-100.
107. Canton R, Manzanares J, Alvarez E, et al. In vitro and in vivo antiaggregant effects of magnesium halogenates. Thromb Haemost 1987;58:957-9.
108. Lox CD, Dorsett MM, Hampton RM. Observations on clotting activity during pre-eclampsia. Clin Exp Hypertens B 1983;2:179-90.
109. Paolisso G, Tirelli A, Coppola L, et al. Magnesium administration reduces platelet hyperaggregability in NIDDM. Diabetes Care 1989;12:167-8.
110. Shechter M. The role of magnesium as antithrombotic therapy. Wien Med Wochenschr 2000;150:343-7.
111. Kitli?ski M, Stepniewski M, Nessler J, et al. Is magnesium deficit in lymphocytes a part of the mitral valve prolapse syndrome? Magnes Res 2004;17:39-45.
112. Lichodziejewska B, K?o? J, Rezler J, et al. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol 1997;79:768-72.
113. Chaudhary DP, Boparai RK, Bansal DD. Implications of oxidative stress in high sucrose low magnesium diet fed rats. Eur J Nutr 2007;46:383-90.
114. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial. Arch Med Res 2014;45:325-30.
115. Guerrero-Romero F, Simental-Mendia LE, Hernandez-Ronquillo G, et al. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: a double-blind placebo-controlled randomized trial. Diabetes Metab 2015;41:202-7.
116. Szabo C, Hardebo JE, Salford LG. Role of endothelium in the responses of human intracranial arteries to a slight reduction of extracellular magnesium. Exp Physiol 1992;77:209-11.
117. Amighi J, Sabeti S, Schlager O, et al. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke 2004;35:22-7.
118. Cojocaru IM, Cojocaru M, Burcin C, et al. Serum magnesium in patients with acute ischemic stroke. Rom J Intern Med 2007;45:269-73.